We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
RenaissanceRe's (RNR) Q1 Earnings Beat on Higher Premiums
Read MoreHide Full Article
RenaissanceRe Holdings Ltd.’s (RNR - Free Report) first-quarter 2018 operating earnings per share of $3.40 beat the Zacks Consensus Estimate of $2.71 by 25.5%. However, the bottom line skyrocketed 161.5% year over year.
RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise
The quarter under review witnessed low level of catastrophes, sturdy premium growth, prior-year favorable development and an improved operating efficiency.
Including adjusted loss on investments and income tax benefits, the company incurred net income of $1.42 per share in the first quarter compared with the same of $2.25 in the year-ago quarter.
Quarterly Operational Update
RenaissanceRe’s first-quarter operating revenues of $415 million missed the Zacks Consensus Estimate of $445 million and declined 1.66% year over year.
Gross premiums written increased 25.8% year over year to $1.2 billion, driven by higher premiums from the Property as well as Casualty and Specialty segments.
Net investment income is $56.5 million for the reported quarter, improved by nearly 4% year-over-year.
RenaissanceRe’s total expenses were $329.2 million, down 3% year over year.
Underwriting income of $129.6 million increased 205.7% from the year-ago quarter.
Combined ratio of 70.6% improved 1780 basis points (bps) from the year-ago quarter.
Quarterly Segment Update
Property Segment
Gross premiums written were $707 million, up 35.8% year over year. This improvement is attributable to higher written premiums in the catastrophe class of business as well as an increase in ceded premiums.
Underwriting income of $127.2 million improved 39.2% from the prior-year quarter.
Combined ratio of 43.5% improved 760 bps from 51.1% in the year-ago quarter.
Casualty and Specialty Segment
Gross premiums written were $452.7 million, up 12.7% from the prior-year quarter of $401.6 million, driven by selective growth from new and existing business wherein the company found attractive risk-return attributes.
Underwriting income of $2.6 million rebounded from the year-ago quarter underwriting loss of $49.3 million.
Combined ratio of 98.8% improved 2870 bps from the year-ago quarter. This upside was particularly driven by a 20.8 percentage point decrease in the Casualty and Specialty segment net claims and claim expenses ratio.
Financial Position
As of Mar 31, 2018, total assets of RenaissanceRe were $15.9 billion, up 4.6% from 2017-end level.
The company had total debt of $989.9 million as of Mar 31 2018, almost flat with 2017-end level.
Cash and cash equivalents were $0.6 billion, down 52.4% from $1.4 billion as of Dec 31, 2017.
Book value per share is $100.29 improved 0.6% year-over-year.
Return on equity expanded 870 basis points to 13.5% from the 2017-end level of 4.8%.
Among other players from the same industry, which have already reported first-quarter earnings, the bottom line of The Progressive Corporation (PGR - Free Report) and RLI Corp. (RLI - Free Report) outpaced the respective Zacks Consensus Estimate while that of The Travelers Companies, Inc. (TRV - Free Report) missed the same.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
RenaissanceRe's (RNR) Q1 Earnings Beat on Higher Premiums
RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise
RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise | RenaissanceRe Holdings Ltd. Quote
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>